News

xMD Investment Highlights

xMD, a pre-commercial private company, is raising a Series-A Preferred Stock financing.

  •  Capital Efficient Business Model
  •  Fast Growing Molecular Dx/NGS Market
  •  Attractive Regulatory/Price Risk Profile
  •  Short time to commercialization
  •  Experienced Leadership Team
  •  High IRR Return Potential